Philip Morris International has successfully acquired the leading global manufacturer of snuff and nicotine pouches, Swedish Match. This move will expand the tobacco giant's footprint in the non-combustible tobacco and nicotine products market.
Philip Morris International (PMI) proposed the acquisition of Swedish Match in May, raising its offering price from SEK 106 (approximately USD 10.22) to SEK 116 per share. According to a report by Reuters on November 7th, 83% of investors have already accepted the proposal, resulting in a loss of approximately $16 billion for PMI. Several major investors fought against the deal for months but ultimately decided to sell.
PMI will continue to pursue the majority shareholder of Swedish Match until it reaches 90% ownership. At that point, remaining investors will be compelled to sell and PMI can make Swedish Match a fully owned subsidiary rather than operating as a separate company.
PMI will enter the US market through its acquisition of Swedish Match.
This deal will immediately position PMI in the American market, where nicotine pouches are a rapidly growing product category and Sweden's Match ZYN brand is the top seller. The company also plans to launch its heated tobacco product IQOS in the US by 2024, after regaining distribution rights from former partner Altria Group. Sweden's Match also provides PMI with an existing sales and distribution infrastructure in the US.
Philip Morris International is the world's largest tobacco company, second only to state-owned China Tobacco. The company was established in 2008, when the international division of US-based Philip Morris spun off and granted PMI the exclusive rights to sell Philip Morris products outside the US, while the original company (now known as Altria Group) sold the same products domestically. Although PMI is headquartered in Switzerland and currently doesn't sell any products in the US, technically its headquarters are located in New York City.
Buying Swedish matches is part of the PMI plan, which aims to shift more than half of its global revenue from combustible products to smoke-free products by 2025. Smoke-free products currently make up around 30% of the company's business, although IQOS almost entirely contributes to that revenue.
Philip Morris International (PMI) is planning to submit a pre-market tobacco application (PMTA) to the FDA next year for its electronic liquid electronic cigarette device, IQOS VEEV (the company's use of the IQOS name for its heated tobacco and liquid electronic cigarette products is confusing).
Swedish Match: Snus, Nasal Snuff, and Reducing the Harm of Tobacco.
Swedish Match is the world's largest tobacco company that does not sell cigarettes, although it does still own the White Owl cigar brand. In 1999, the company sold its remaining cigarette business to Austria's Tabak. Since then, Swedish Match has been praised for its leadership in promoting Tobacco Harm Reduction (THR) by encouraging smokers to switch to low-risk nicotine alternatives instead of cigarettes.
Swedish Match is the leading manufacturer of snus, a moist oral tobacco product sold in small pouches. In Sweden, the number of snus users now surpasses cigarette smokers, and the daily smoking rate among adults has dropped to around 5%. A similar trend is observed in neighboring Norway, where snus is also popular. When Sweden joined the European Union in 1995, it was given an exemption from the EU ban on snus.
While not a main tobacco product in the United States, several common brands of Swedish snus, a type of smokeless tobacco, were among the first tobacco or nicotine products authorized by the Food and Drug Administration (FDA) under the PMTA and MRTP pathways. (The IQOS device also received PMTA and MRTP authorization.) However, nicotine pouches are quickly gaining ground in the US market, with Swedish Match leading the way in this category with their ZYN brand.
The FDA has not yet made a decision on the PMTA submitted by the nicotine pouch manufacturer. The agency may reject electronic cigarette pouches entirely, as they are actually made with flavors such as mint, citrus, coffee, and fruit, and the FDA has indicated in its handling of PMTA for electronic cigarette products that it may not be willing to authorize any flavored "tobacco products.
Anti-nicotine and tobacco groups in the United States and Europe are opposing the sale of nicotine pouches, even if they do not contain tobacco and have risk characteristics almost identical to nicotine replacement therapy (NRT) products like nicotine gum. Nicotine pouches are legal in most European countries.
In some Asian and African countries, nasal snuff and nicotine pouches may be game-changing products, where many countries either have a strong tradition of oral tobacco use (especially in India and Bangladesh) or are relatively new to tobacco and nicotine use (smoking is only just becoming popular in many African countries). Nicotine pouches, in particular, are easy to manufacture and transport, and are heat and cold-resistant, making storage a simplified process.
Swedish Match produces products in seven countries, including the United States, and has offices in four other countries. The company's sales in 2021 were approximately $1.8 billion.
Statement:
This article is compiled from third-party information and is intended for industry professionals for sharing and learning purposes.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is intended solely for industry communication and research purposes.
Due to limitations in the level of translation, the translated article may not accurately convey the same meaning as the original. Therefore, please refer to the original article for accurate information.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expressions and stances.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
